At the latest International Dental Show (IDS) 2021 in Cologne, Germany, Neoss held a press conference with special guest Dr Marcus Dagnelid, a prosthodontist from Sweden. Neoss presented their past and present innovations and introduced their strategic partnership with Purgo Biologics that will expand the Bone Regeneration product line. Neoss® made the announcement at IDS as part of the company’s continued support for Koelnmesse and the event.
In 2021, Neoss® has seen significant growth in sales and expansion into new business areas. The Neoss ProActive® Edge implant and the NeossONE™ concept also received industry leading attendance and attention during its global campaigns.
As well as investing heavily in continued innovation of the Neoss® product lines, Neoss actively creates key strategic partnerships across the globe to better service their customers with an extended offering.
The first product out of the Purgo Biologics partnership is THE Graft™, a natural porous bone matrix that likens the physical and chemical aspects of the mineralised matrix of human bone. The exciting Xenograft product line will add new dimensions to Neoss®’ existing Bone Regeneration offering.
Dr Dagnelid showed how THE Graft™ was utilised in his ridge preservation after tooth extraction. This can be used both within conventional dentistry as well as implant dentistry. This procedure is a real benefit for the patient and for the long-term success of the treatment.